Drug therapy: Imatinib mesylate - A new oral targeted therapy.

被引:637
作者
Savage, DG [1 ]
Antman, KH [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
关键词
D O I
10.1056/NEJMra013339
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:683 / 693
页数:11
相关论文
共 126 条
[1]   UK MEDICAL-RESEARCH-COUNCIL RANDOMIZED, MULTICENTER TRIAL OF INTERFERON-ALPHA-N1 FOR CHRONIC MYELOID-LEUKEMIA - IMPROVED SURVIVAL IRRESPECTIVE OF CYTOGENETIC RESPONSE [J].
ALLAN, NC ;
RICHARDS, SM ;
SHEPHERD, PCA .
LANCET, 1995, 345 (8962) :1392-1397
[2]  
AMBACORTIPASSER.C, 2000, JNCI-J NATL CANCER I, V92, P1341
[3]  
Apperley JF, 2001, BLOOD, V98, p726A
[4]   Paraffin section detection of the c-kit gene product (CD117) in human tissues:: Value in the diagnosis of mast cell disorders [J].
Arber, DA ;
Tamayo, R ;
Weiss, LM .
HUMAN PATHOLOGY, 1998, 29 (05) :498-504
[5]   Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia [J].
Aricò, M ;
Valsecchi, MG ;
Camitta, B ;
Schrappe, M ;
Chessells, J ;
Baruchel, A ;
Gaynon, P ;
Silverman, L ;
Janka-Schaub, G ;
Kamps, W ;
Pui, CH ;
Masera, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) :998-1006
[6]   Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo [J].
Barnhill, RL ;
Xiao, M ;
Graves, D ;
Antoniades, HN .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (06) :898-904
[7]   TRANSLOCATION OF C-ABL ONCOGENE CORRELATES WITH THE PRESENCE OF A PHILADELPHIA-CHROMOSOME IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
BARTRAM, CR ;
DEKLEIN, A ;
HAGEMEIJER, A ;
VANAGTHOVEN, T ;
VANKESSEL, AG ;
BOOTSMA, D ;
GROSVELD, G ;
FERGUSONSMITH, MA ;
DAVIES, T ;
STONE, M ;
HEISTERKAMP, N ;
STEPHENSON, JR ;
GROFFEN, J .
NATURE, 1983, 306 (5940) :277-280
[8]  
BEDI A, 1994, BLOOD, V83, P2038
[9]   PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME [J].
BEELEN, DW ;
GRAEVEN, U ;
ELMAAGACLI, AH ;
NIEDERLE, N ;
KLOKE, O ;
OPALKA, B ;
SCHAEFER, UW .
BLOOD, 1995, 85 (10) :2981-2990
[10]  
Beran M, 1998, CLIN CANCER RES, V4, P1661